RESTON, Va., Jan. 23 /PRNewswire-FirstCall/ -- PRA International , a leading clinical research organization, will release full year 2006 earnings results and host an accompanying conference call on Wednesday, February 28, 2007. Following the pre-market release, the conference call will begin at 9:00 a.m. Eastern, hosted by CEO Terrance J. Bieker and Executive Vice President and CFO Matt Bond. In addition to providing 2006 year-end financial results, PRA management will provide an operational assessment of the business and financial guidance for 2007.
"I am proceeding with a methodical assessment of PRA's strategy, operations and business model," said Bieker. "Our entire team is working together to leverage our core strengths to drive future growth."
PRA also reiterated that its 2006 service revenue guidance is in a range of $300 to $305 million and that fully diluted earnings per share for 2006 is in a range of $1.08 to $1.11.
The conference call will be available live via webcast and telephone. To participate on the webcast, log on to http://www.prainternational.com at least 15 minutes early to register, download and install any necessary audio software. The call may also be accessed by dialing 866-770-7051 or 617-213-8064. A replay of the call will remain available at the site for 30 days.
Cautionary Note Regarding Forward-Looking Statements
This news release contains forward-looking statements that are subject to risks and uncertainties relating to PRA International's future financial and business performance, as well as any other predictive statements that depend on future events or conditions, or that include words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "may," "will," "estimate" or similar expressions of futurity. You should not place undue reliance on any forward-looking statements, which represent the company's statements only as of the date of this news release and are not intended to give any assurance as to actual future events. Factors that might cause future events to differ include: operational and personnel challenges that could result from management changes; the results of the executive search process; the ability to execute our strategy during management transitions; the ongoing need for early and late phase drug development services; project cancellations and timing issues; our ability to attract and retain qualified personnel; our ability to continue providing our services effectively, including the quality or accuracy of the data or reports provided and our ability to meet agreed- upon schedules; the ability and willingness of our clients to continue to spend on research and development at rates comparable to or greater than historical levels; trends or events affecting the CRO industry and the demand for CRO services; government regulation, including regulatory standards applicable to CRO services; evolving industry standards and technological changes; and general business and economic conditions. Events relating to PRA International could differ materially from those anticipated in these forward- looking statements. Although these statements are based upon assumptions company management believes to be reasonable based upon available information, they are subject to the foregoing risks and uncertainties as well as those described more fully in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of our annual report on Form 10-K. This document can be accessed in the SEC's EDGAR database found at http://www.sec.gov . Please note that PRA International assumes no obligation to update any of the forward-looking statements in this release, except as required by applicable securities laws.
About PRA International
PRA International is one of the world's leading global clinical development organizations, with over 2,700 employees working from offices in North America, Europe, South America, Africa, Australia and Asia. PRA, an ISO 9001:2000 registered company, delivers services to its clients through a unique approach called Project Assurance(R), which represents the Company's commitment to reliable service delivery, program-level therapeutic expertise, easy, global access to knowledge and involved senior management.
To learn more about PRA International, please visit http://www.prainternational.com or call our World Headquarters at +1 (703) 464-6300.
PRA InternationalCONTACT: Investors-Analysts, Matt Bond, Executive Vice President & CFO, ofPRA International, +1-703-464-6300, or Kathy Waller of Financial RelationsBoard, +1-312-640-6696; or Media, John Lewis, Director-Marketing and PublicRelations, of PRA International, +1-703-464-6338, lewisjohn@praintl.com
Web site: http://www.prainternational.com/
